Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anthropogenic disturbance homogenizes seagrass fish communities.
Iacarella JC, Adamczyk E, Bowen D, Chalifour L, Eger A, Heath W, Helms S, Hessing-Lewis M, Hunt BPV, MacInnis A, O'Connor MI, Robinson CLK, Yakimishyn J, Baum JK. Iacarella JC, et al. Among authors: helms s. Glob Chang Biol. 2018 May;24(5):1904-1918. doi: 10.1111/gcb.14090. Epub 2018 Mar 2. Glob Chang Biol. 2018. PMID: 29431880
The history of the microscope reflects advances in science and medicine.
Noble CA, Biesemier AP, McClees SF, Alhussain AM, Helms SE, Brodell RT. Noble CA, et al. Among authors: helms se. Semin Diagn Pathol. 2024 Jan 11:S0740-2570(24)00003-0. doi: 10.1053/j.semdp.2024.01.002. Online ahead of print. Semin Diagn Pathol. 2024. PMID: 38627186 Review.
What Can Be Done for Ostomy Dermatitis?
Helms SE, Glasgow WC, Newlon H, Nahar VK. Helms SE, et al. Dermatitis. 2024 Mar-Apr;35(2):178-179. doi: 10.1089/derm.2023.0067. Epub 2024 Feb 29. Dermatitis. 2024. PMID: 38422212 No abstract available.
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
Functional Status and Quality of Life 6 Months After Extracorporeal Membrane Oxygenation Therapy for COVID-19-Related Pulmonary Failure.
Guenther SPW, Cheaban R, Hoepner L, Weinrautner N, Kirschning T, Al-Khalil R, Bruenger F, Serrano MR, Barndt I, Wiemer M, Niedermeyer J, Rudloff M, Helms S, Schramm R, Gummert JF. Guenther SPW, et al. Among authors: helms s. ASAIO J. 2023 Oct 1;69(10):942-949. doi: 10.1097/MAT.0000000000001993. Epub 2023 May 31. ASAIO J. 2023. PMID: 37256794
Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical Trial.
Kishnani PS, Diaz-Manera J, Toscano A, Clemens PR, Ladha S, Berger KI, Kushlaf H, Straub V, Carvalho G, Mozaffar T, Roberts M, Attarian S, Chien YH, Choi YC, Day JW, Erdem-Ozdamar S, Illarioshkin S, Goker-Alpan O, Kostera-Pruszczyk A, van der Ploeg AT, An Haack K, Huynh-Ba O, Tammireddy S, Thibault N, Zhou T, Dimachkie MM, Schoser B; COMET Investigator Group. Kishnani PS, et al. JAMA Neurol. 2023 Jun 1;80(6):558-567. doi: 10.1001/jamaneurol.2023.0552. JAMA Neurol. 2023. PMID: 37036722 Free PMC article. Clinical Trial.
140 results